Delivery Order SPE2DX22D0099-SPE2D825FAP1S
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $119,950.23 to AmerisourceBergen Drug Corp on September 18, 2025, with completion targeted for the same date. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion pharmaceutical support vehicle extending through December 2026. The delivery order will be...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $27,768.48 to AmerisourceBergen Drug Corp on July 9, 2025, with an ultimate completion date of July 10, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The work will be performed at...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,083.60 to AmerisourceBergen Drug Corp on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. The award was competitively granted with no set-aside designation, reflecting the...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $508,939.33 to AmerisourceBergen Drug Corp on July 24, 2025, with completion expected by July 25, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively awarded without set-aside designation to the vendor's...
- The Defense Logistics Agency's Medical Supply Chain awarded a $561,251.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for completion by July 29, 2025. This non-competitive, non-set-aside delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is being performed at the awardee's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on July 26, 2025, with ultimate completion by July 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $41,589.18 to AmerisourceBergen Drug Corp on June 5, 2025, with an ultimate completion date of June 6, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,913.99 to AmerisourceBergen Drug Corp on July 31, 2025, with a completion date of the same day. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation, and...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $21,197.66 to AmerisourceBergen Drug Corp on August 9, 2025, with completion scheduled for August 11, 2025. This firm fixed-price, non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be performed at the contractor's corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $109,461.87 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order, designated as a non-set-aside competitive award, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026. The order...
- SPE2DX22D0099Indefinite Delivery Contract
- SPE2DX22D0099-SPE2D825FAP1SDelivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $359,199.68 to AmerisourceBergen Drug Corp on July 10, 2025, with an ultimate completion date of July 11, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award is non-competitive, as it is issued against an existing IDC vehicle, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. Through its comprehensive IDC with DLA Troop Support Medical, the company supplies a broad range of pharmaceutical products and medical commodities, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare products across multiple therapeutic domains. This delivery order continues the company's ongoing support for federal military healthcare programs and demonstrates AmerisourceBergen's critical role in sustaining pharmaceutical supply chains for Defense Department operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $359.2k | 7/10/25 |